GLP-1ras and Its Impact on Eating Disorders
GLP-1ras and Its Impact on Eating Disorders The perpetuation of diet culture is aggravated partly by the misuse of weight-loss medications by unintended populations. Glucagon-like peptide-1 receptor agonist (GLP-1ras) is one of the most prevalent types of medication–commonly found under the names of Ozempic, Mounjaro, Saxenda, Victoza, Wegovy, Zepbound, etc. Learn how balance can support you It is approved by the Federal Drug Administration for Type 2 diabetes treatment and chronic weight management. However, the misuse of GLP-1ras for weight loss to fit the thin idealization is populating around online platforms by uncertified “wellness” influencers and affiliated individuals benefiting